What is the current Price Target for the NextCure, Inc. stock?

The average NextCure, Inc. target price is $36.72. This is 650.92% higher than the current stock price. The highest price target is 673.01%, the lowest is 643.56%. 4 Analysts have issued a price target NextCure, Inc. 2026 .

How high will the NextCure, Inc. stock rise?

No reliable answer can be given as to how high the NextCure, Inc. stock will rise. The performance of stocks, including the NextCure, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the NextCure, Inc. stock today?

The performance of NextCure, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the NextCure, Inc. stock fall?

The decline in NextCure, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

NextCure, Inc. Forecast, price target & analysts

$4.89

1.41% yesterday

Nasdaq, Aug 01, 10:04 pm CET

ISIN

US65343E1082

Symbol

NXTC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

NextCure, Inc. Target price 2025 - Analyst rating & recommendation

NextCure, Inc. Classifications & Recommendation:

Buy

88%

Hold

13%

NextCure, Inc. Price Target

Target Price	$36.72
Price	$4.89
Potential	650.92% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target NextCure, Inc. 2026 . The average NextCure, Inc. target price is $36.72. This is 650.92% register free of charge higher than the current stock price. The highest price target is $37.80 673.01% register free of charge , the lowest is $36.36 643.56% register free of charge .
	A rating was issued by 8 analysts: 7 Analysts recommend NextCure, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the NextCure, Inc. stock has an average upside potential 2026 of 650.92% register free of charge . Most analysts recommend the NextCure, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.99	-1.56
	11.56%	21.61%
P/E		negative

5 Analysts have issued a NextCure, Inc. forecast for earnings per share. The average NextCure, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.99	11.56%
2025	$-1.56 21.61% Unlock
2026	$-1.46 6.41% Unlock
2027	$-0.94 35.62% Unlock
2028	$-0.65 30.85% Unlock
2029	$-0.52 20.00% Unlock
2030	$0.05 109.62% Unlock

Current	-0.23	68.97%
2025	-3.14 1,251.12% Unlock
2026	-3.35 6.69% Unlock
2027	-5.21 55.52% Unlock
2028	-7.49 43.76% Unlock
2029	-9.40 25.50% Unlock
2030	95.88 1,120.00% Unlock

NextCure, Inc....

Current NextCure, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Piper Sandler	Locked ➜ Locked	Locked	Jul 15 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jul 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 17 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 07 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 11 2024

Analyst Rating	Date
Locked Piper Sandler: Locked ➜ Locked	Jul 15 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jul 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 17 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 07 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 11 2024

Discover more stocks with a high price target

BioNTech SE - ADR 30.66%

Alibaba Group Holding Ltd 27.33%

MongoDB 26.94%

Deutsche Telekom 24.51%

Infineon 22.22%

Tencent Holdings Ltd. 21.83%

PayPal 21.59%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now